Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

Investors increased their allocations to pharmaceuticals (NYSEARCA:PJP), (NYSEARCA:XPH), (PPH), banks (KRE) and industrials ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.

Revenue: US$2.73m (down 33% from 3Q 2023). Net loss: US$162.0m (loss narrowed by 8.5% from 3Q 2023). US$0.86 loss per share ...

WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

The American company West Pharmaceutical Services is to create another 330 jobs as part of an expansion of its manufacturing ...

Ascendis Pharma (ASND) has released an update. Ascendis Pharma A/S has structured its capital to enable significant growth opportunities, with ...

With the respiratory illness season starting up in earnest, Vicks has reclaimed the top Rx and over-the-counter (OTC) pharma ...

Urogen's UGN-102 presents a $5B market opportunity for bladder cancer treatment, despite risks. Read more about URGN stock ...

Ascendis Pharma (ASND) is scheduled to announce Q3 earnings results on Thursday, November 14th, after market close. The ...

The deal is expected to provide SPIMACO with a significant opportunity to strengthen its product portfolio, enhance its ...